Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
Guntinas-Lichius
Orlando
O
Department of Otorhinolarynology-Head and Neck Surgery, University of Cologne, koeln, Germany. orlando.guntinas@uni-koeln.de
D000368:Aged; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001764:Blepharospasm / Q000188:drug therapy*; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D013547:Sweating, Gustatory / Q000188:drug therapy*; D017211:Treatment Failure; D014832:Voice Disorders / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A